Overview
Localized pulmonary fibrosis refers to the scarring of lung tissue that primarily affects specific areas rather than being diffuse. It can result from various etiologies including occupational exposures, infections, and post-COVID-19 complications. 12132946556069Diagnosis
Management
Special Populations
Key Recommendations
References
1 Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M et al.. Nerandomilast in Patients with Progressive Pulmonary Fibrosis. The New England journal of medicine 2025. link 2 Li M, Huang H, Wei X, Li H, Li J, Xie B et al.. Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment. Signal transduction and targeted therapy 2025. link 3 Wu X, Xiao X, Su Y, Zhang Y, Li G, Wang F et al.. Use quercetin for pulmonary fibrosis: a preclinical systematic review and meta-analysis. Inflammopharmacology 2025. link 4 Bermudo-Peloche G, Del Rio B, Vicens-Zygmunt V, Bordas-Martinez J, Hernández M, Valenzuela C et al.. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. The European respiratory journal 2025. link 5 Duong-Quy S, Nguyen Hai C, Huynh-Anh T, Nguyen-Nhu V. Tackling pulmonary fibrosis risks in post-COVID-19: cutting-edge treatments. Expert opinion on pharmacotherapy 2025. link 6 Wuyts WA, Bonella F, Chaudhuri N, Varone F, Antin-Ozerkis D, Song JW et al.. Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON. Lung 2025. link 7 Kreuter M, Maher TM, Wuyts WA, Valenzuela C, Hamblin M, Kim S et al.. Effect of Admilparant, a Lysophosphatidic Acid Receptor 1 Antagonist, on Disease Progression in Pulmonary Fibrosis. Chest 2025. link 8 Brennan PJ, Wiesner DL. Fungal cues, fibrotic consequences: Commensal sensing by alveolar macrophages promotes pulmonary fibrosis. Cell host & microbe 2025. link 9 Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T et al.. Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. The European respiratory journal 2024. link 10 Geng Q, Yan L, Shi C, Zhang L, Li L, Lu P et al.. Therapeutic effects of flavonoids on pulmonary fibrosis: A preclinical meta-analysis. Phytomedicine : international journal of phytotherapy and phytopharmacology 2024. link 11 Chen Y, Zhong J, Cai Z, Xia Z, Qing B, Yuan Y et al.. Meta-analysis of the association between sex hormones and pulmonary fibrosis. Postgraduate medicine 2024. link 12 Podolanczuk AJ, Aronson KI. Nintedanib and symptoms of fibrotic lung disease: a glimmer of hope for patients living with pulmonary fibrosis. The European respiratory journal 2024. link 13 McCall KL, Hennig KR, Abe ZT, Dattler DN, Hurd KL, Portnoy SL et al.. Rising cases of drug-induced pulmonary fibrosis: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database, 2000-2022. Pharmacoepidemiology and drug safety 2024. link 14 Gao Y, Zhao L, Yang Z, He K, Zhang T, Yi J. Efficacy of exercise in patients with pulmonary fibrosis: A systematic review and meta-analysis. Medicine 2022. link 15 Librero Jiménez M, Heredia Carrasco C, Fernández Cano MDC. Severe hepatotoxicity secondary to nintedanib. Revista espanola de enfermedades digestivas 2022. link 16 Christian K, Hey-Cunningham A, Corte T, Goh N, Jaffar J, Reynolds P et al.. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC medical education 2022. link 17 Zhao Y, Hao C, Li M, Qu Y, Guo Y, Deng X et al.. PD-1/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022. link 18 Finnerty JP, Ponnuswamy A, Dutta P, Abdelaziz A, Kamil H. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis. BMC pulmonary medicine 2021. link 19 Zhou S, Wang X, Gao H, Zeng Y. DNA Methylation in Pulmonary Fibrosis. Advances in experimental medicine and biology 2020. link 20 Sari E, Oztay F, Tasci AE. Vitamin D modulates E-cadherin turnover by regulating TGF-β and Wnt signalings during EMT-mediated myofibroblast differentiation in A459 cells. The Journal of steroid biochemistry and molecular biology 2020. link 21 Blackley DJ, Reynolds LE, Short C, Carson R, Storey E, Halldin CN et al.. Progressive Massive Fibrosis in Coal Miners From 3 Clinics in Virginia. JAMA 2018. link 22 Harnisch LO, Moerer O. Sequential use of extracorporeal devices to avoid mechanical ventilation in a patient with complicated pulmonary fibrosis. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 2017. link 23 Roels E, Couvreur T, Farnir F, Clercx C, Verschakelen J, Bolen G. COMPARISON BETWEEN SEDATION AND GENERAL ANESTHESIA FOR HIGH RESOLUTION COMPUTED TOMOGRAPHIC CHARACTERIZATION OF CANINE IDIOPATHIC PULMONARY FIBROSIS IN WEST HIGHLAND WHITE TERRIERS. Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 2017. link 24 Sheveleva EV, Ilkovich MM, Novikova LN, Pearley VE, Dzadzua DV, Dolinina LY. DIAPHRAGM KINETICS IN PULMONARY FIBROSIS PATIENTS AND GASTROESOPHAGEAL REFLUX. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 2016. link 25 Danby J. Filming the dangers of smoking. Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2016. link 26 Richeldi L, Collard HR, du Bois RM, Jenkins G, Kolb M, Maher TM et al.. Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis. The European respiratory journal 2013. link 27 Garantziotis S, Schwartz DA. Host-environment interactions in pulmonary fibrosis. Seminars in respiratory and critical care medicine 2006. link 28 Fujita M, Ye Q, Ouchi H, Harada E, Inoshima I, Kuwano K et al.. Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice. Antimicrobial agents and chemotherapy 2006. link 29 Descatha A, Mompoint D, Ameille J. Occupational paraffin-induced pulmonary fibrosis: a 25-year follow-up. Occupational medicine (Oxford, England) 2006. link 30 Chen JY, Zheng MF, Jing ZH, Wang YG, Zhu QK, Chen R. Case report: a left donor lung implanted in the recipient's right thorax for the therapy of pulmonary fibrosis. Transplantation proceedings 2006. link 31 Ninio DM, Hii JT. An ill wind-iatrogenic air embolus around pacing leads during defibrillator implant with coexisting pulmonary fibrosis. Pacing and clinical electrophysiology : PACE 2006. link 32 Menon B, Sharma A, Kripalani J, Jain S. Giant cell interstitial pneumonia in a 60-year-old female without hard metal exposure. Respiration; international review of thoracic diseases 2006. link 33 Dunsmore SE, Shapiro SD. The bone marrow leaves its scar: new concepts in pulmonary fibrosis. The Journal of clinical investigation 2004. link 34 Wilcox A. High-resolution CT: what is it good for in pulmonary fibrosis?. Current opinion in pulmonary medicine 2003. link 35 Webb JA, Armstrong J. Chronic idiopathic pulmonary fibrosis in a West Highland white terrier. The Canadian veterinary journal = La revue veterinaire canadienne 2002. link 36 Otake S, Takahashi M, Ishigaki T. Focal pulmonary interstitial opacities adjacent to thoracic spine osteophytes. AJR. American journal of roentgenology 2002. link 37 Chow SK, Yeap SS. Amyopathic dermatomyositis and pulmonary fibrosis. Clinical rheumatology 2000. link 38 Yi ES, Lee H, Yin S, Piguet P, Sarosi I, Kaufmann S et al.. Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. The American journal of pathology 1996. link 39 Ferretti G, Boutelant M, Thony F, Carpentier F, Pison C, Guignier M. Successful stenting of a pulmonary arterial stenosis after a single lung transplant. Thorax 1995. link 40 Sansores RH, Villalba-Caloca J, Ramirez-Venegas A, Salas J, Carrillo G, Chapela R et al.. Reversal of digital clubbing after lung transplantation. Chest 1995. link 41 Zhang K, Flanders KC, Phan SH. Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. The American journal of pathology 1995. link 42 Savin H, Huberman M, Kott E, Lishner M, Kitai Y, Kidron D et al.. Fibrosing alveolitis associated with primary antiphospholipid syndrome. British journal of rheumatology 1994. link 43 Fried ED, Godwin TA. Extensive diffuse pulmonary ossification. Chest 1992. link 44 Bero CJ, Rihn TL. Possible association of pulmonary fibrosis with mexiletine. DICP : the annals of pharmacotherapy 1991. link 45 Naughton M, Irving L, McKenzie A. Pneumomediastinum after a transbronchial biopsy. Thorax 1991. link 46 Sherson D, Maltbaek N, Heydorn K. A dental technician with pulmonary fibrosis: a case of chromium-cobalt alloy pneumoconiosis?. The European respiratory journal 1990. link 47 Makker H, McConnochie K, Gibbs AR. Postirradiation pulmonary fibrosis complicated by aspergilloma and bronchocentric granulomatosis. Thorax 1989. link 48 Parra O, Ruiz J, Ojanguren I, Navas JJ, Morera J. Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug. The European respiratory journal 1989. link 49 Ono M, Arakawa K, Mori M, Sugimoto T, Harashima H. Separation of fine crackles from vesicular sounds by a nonlinear digital filter. IEEE transactions on bio-medical engineering 1989. link 50 Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. Journal of clinical pathology 1988. link 51 Raju S, Coltharp WH, Gerken MV, Warren ET, Griffith J, Hardy JD. Successful single lung transplantation. Southern medical journal 1988. link 52 Dark J, Cooper JD. Transplantation of the lungs. British journal of hospital medicine 1987. link 53 Miller WC, Heard JG, Unger KM, Suich DM. Anatomical lung shunting in pulmonary fibrosis. Thorax 1986. link 54 Doll DC. Fatal pneumothorax associated with bleomycin-induced pulmonary fibrosis. Cancer chemotherapy and pharmacology 1986. link 55 Dvorácková I, Píchová V. Pulmonary interstitial fibrosis with evidence of aflatoxin B1 in lung tissue. Journal of toxicology and environmental health 1986. link 56 Bellot SM, Schade van Westrum JA, Wagenvoort CA, Meijer AE. Deposition of bauxite dust and pulmonary fibrosis. Pathology, research and practice 1984. link80134-X) 57 Ghadially FN, Murphy F, Lalonde JM. Diagnosis of pulmonary talcosis by electron-probe x-ray analysis. Journal of submicroscopic cytology 1984. link 58 McLean RG, Choy D, Murray IP. Unexpected gallium uptake in benign pulmonary pathology. Report of two cases. Clinical nuclear medicine 1984. link 59 Butland RJ, Millard FJ. Fibrosing alveolitis associated with amiodarone. European journal of respiratory diseases 1984. link 60 Abdel Karim FW, Ayash RE, Allam C, Salem PA. Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report. Oncology 1983. link 61 Quyyumi AA, Ormerod LP, Clarke SW, Evans TR, Ward RL. Pulmonary fibrosis--a serious side-effect of amiodarone therapy. European heart journal 1983. link 62 Yamaguchi H, Usui H, Tajima T. Pulmonary fibrosis of low calcium diet fed guinea pigs induced by the administration of a soluble immune complex. Experimental pathology 1981. link80063-1) 63 Smith P, Heath D. The ultrastructure of age-associated intimal fibrosis in pulmonary blood vessels. The Journal of pathology 1980. link 64 Miyamoto T, Ichikawa K, Hasegawa M, Horiuchi Y. Pulmonary fibrosis caused by delayed-type hypersensitivity reaction in guinea pigs. Annals of allergy 1980. link 65 Lieberman A, Ruoff M, Estey E, Seidman I, Lieberman I, Wise A. Irreversible pulmonary toxicity after single course of BCNU. The American journal of the medical sciences 1980. link 66 Mackay GR, Stettler LE, Kommineni C, Donaldson HM. Fibrogenic potential of slags used as substitutes for sand in abrasive blasting operations. American Industrial Hygiene Association journal 1980. link 67 Huuskonen MS, Tiilikainen A, Alanko K. HLA-B18 antigens and protection from pulmonary fibrosis in asbestos workers. British journal of diseases of the chest 1979. link 68 Eberl R, Bröll H. Penicillamine in the treatment of pulmonary fibrosis. Agents and actions. Supplements 1979. link 69 Forrest ME, Skerker LB, Nemiroff MJ. Hard metal pneumoconiosis: another cause of diffuse interstitial fibrosis. Radiology 1978. link 70 Bailey CC, Marsden HB, Jones PH. Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy. Cancer 1978. link42:1<74::aid-cncr2820420111>3.0.co;2-i) 71 Cole SR, Myers TJ, Klatsky AU. Pulmonary disease with chlorambucil therapy. Cancer 1978. link41:2<455::aid-cncr2820410212>3.0.co;2-z) 72 Turner-Warwick M. Immune reactions in pulmonary fibrosis. Schweizerische medizinische Wochenschrift 1977. link 73 Cruthirds TP, Cole FH, Paul RN. Pulmonary talcosis as a result of massive aspiration of baby powder. Southern medical journal 1977. link 74 Klaff LJ, Levin PJ, Potgieter PD, Losman JG, Nochomovitz LE, Ferguson AD. Treatment of paraquat poisoning with the membrane oxygenator: a case report. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1977. link 75 Motomiya M, Arai H, Sato H, Yokosawa A, Nagai H. Increase of dermatan sulfate in a case of pulmonary fibrosis. The Tohoku journal of experimental medicine 1975. link 76 Yamaguchi H, Takeuchi H, Torikata C, Kageyama K. Experimental pulmonary fibrosis induced by soluble immune complex and 60% oxygen atmosphere. International archives of allergy and applied immunology 1975. link 77 Pariente R, Berry JP, Galle P, Cayrol E, Brouet G. A study of pulmonary dust deposits using the electron microscope in conjunction with the electron sound analyser. Thorax 1972. link 78 Pearson JE, Wilson RS. Diffuse pulmonary fibrosis and hiatus hernia. Thorax 1971. link